Psychiatry

UC Irvine receives funding for clinical trial of neural stem cell therapy for Huntington’s disease

by

Why Stem‑Cell Therapy Could Redefine Huntington’s Disease Care Scientists are closing in on a breakthrough that may shift Huntington’s disease (HD) from a relentless neurodegenerative disorder to a treatable condition. The California Institute for Regenerative Medicine (CIRM) has funneled nearly $12 million into a first‑in‑human trial of an embryonic‑stem‑cell‑derived neural stem cell product, dubbed hNSC‑01. This … Read more

Youth mental health crisis leads to prolonged emergency room stays

by

Kids in Crisis: Unpacking the Mental Health Emergency Room Bottleneck The landscape of pediatric mental healthcare is facing a critical challenge. Recent studies, like the one published in the JAMA Health Forum, are shedding light on a distressing trend: children experiencing mental health crises are increasingly “boarding” in emergency departments (EDs) for extended periods. This … Read more

The role of reward-related brain activity in response to treatment and later depression severity: data from a randomized controlled trial in early adolescents with anxiety disorders

by

Rewiring the Teenage Brain: Future Trends in Mental Health Treatment As a seasoned journalist specializing in mental health, I’ve spent years sifting through research and speaking with experts. The landscape of adolescent mental health is evolving rapidly, and the future holds exciting (and sometimes challenging) developments. This isn’t just about identifying problems; it’s about understanding … Read more

HFSA and ASPC Release Statement on Shifting to Prevention in Heart Failure

by

Heart Failure: A Paradigm Shift Towards Prevention and Proactive Care The landscape of heart failure management is undergoing a significant transformation. A recent joint statement by the Heart Failure Society of America (HFSA) and the American Society for Preventive Cardiology (ASPC) underscores a critical shift: moving away from solely treating heart failure to proactively preventing … Read more

6 Endocrinology Headlines You May Have Missed in July 2025

by

Endocrinology’s Forward March: Key Trends Reshaping Diabetes, CKD, and Growth Hormone Deficiency The field of endocrinology is experiencing a period of unprecedented advancement. From groundbreaking clinical trial results to innovative therapies, the pace of progress in managing conditions like diabetes, chronic kidney disease (CKD), and growth hormone deficiency is accelerating. This article delves into the … Read more

Talking therapy shows lower effectiveness for young adults

by

Talking Therapy’s Achilles’ Heel: Why Young Adults Need Tailored Mental Health Care The National Health Service (NHS) in England offers vital talking therapies, such as Cognitive Behavioral Therapy (CBT), to combat depression and anxiety. However, a recent study published in The Lancet Psychiatry reveals a concerning disparity: these therapies are less effective for young adults … Read more

Remibrutinib for CSU Treatment

by

The Future of CSU Treatment: A Look at Oral Therapies and Patient Empowerment Chronic Spontaneous Urticaria (CSU), also known as chronic hives, can significantly impact a patient’s quality of life. Finding effective and convenient treatments is paramount. Recent advancements, particularly in oral therapies like remibrutinib, are reshaping the landscape, offering new hope and opportunities for … Read more

Semaglutide Reduces Progression of PAD by 54% in Type 2 Diabetes

by

Semaglutide and PAD: Unveiling a Vascular Protective Revolution The medical world is abuzz with the latest findings on semaglutide, particularly its potential to revolutionize the treatment of peripheral artery disease (PAD) in individuals with type 2 diabetes. Recent data from the STRIDE trial, presented at the American Diabetes Association (ADA) Scientific Sessions, suggests the benefits … Read more

Higher Semaglutide Doses Yield Greater Weight Loss in Obesity

by

Semaglutide: A Glimpse into the Future of Obesity Management The medical landscape is constantly evolving, and the recent findings on semaglutide, particularly the higher dose (7.2 mg) of Wegovy, are reshaping how we approach obesity treatment. This injectable medication has shown remarkable results in clinical trials, offering new hope for individuals struggling to manage their … Read more

FDA Grants Orphan Drug Designation to DIAG723 for Treatment of HHT

by

New Hope on the Horizon: Promising Developments in Hereditary Hemorrhagic Telangiectasia (HHT) Treatment For those living with Hereditary Hemorrhagic Telangiectasia (HHT), a rare genetic disorder, managing its effects can be a constant challenge. Characterized by the formation of abnormal blood vessels, HHT often leads to recurrent bleeding and complications like anemia. But recent advancements offer … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: office@newsy-today.com

For contact, advertising, copyright, issues email: office@newsy-today.com